Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults
Clinical trial NCT04747392 · COMPLETED
Trial details
- NCT number
- NCT04747392
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2020-10-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.